Investing News NetworkYour trusted source for investing success

aldeyra therapeutics

Aldeyra Therapeutics Reports Full-Year 2019 Financial Results

Aldeyra Therapeutics Reveals Results from ADX-102 Trial

Aldeyra Therapeutics Shares Financials for Q1 2017

Aldeyra Gets First Patient Enrolled in Phase 3 Trial

Aldeyra Gets Orphan Drug Designation for ADX-102

Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial

Aldeyra Therapeutics, Inc. Prices Public Offering of Common Stock

Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs

Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results

Aldeyra Therapeutics Appoints Richard H. Douglas to Board of Directors

High grade gold in early stage drilling at Sandstone

Blue Sky Uranium Acquires Key Subsurface Data for Corcovo Uranium Project, Mendoza Province, Argentina

Group Eleven Drills Best Hole Yet at Ballywire: 39.7m of 9.5% Zn+Pb, 131 g/t Ag and 0.27% Cu, incl. 5.6m of 16.6% Zn+Pb, 370 g/t Ag and 0.86% Cu

Sale Completion of Non-Core Irish Assets for CAD$ 2.5 million

Questcorp Mining Engages Marketing Consulting Firm Spark Newswire

Sun Summit Minerals

Metals Australia

South Harz Potash Limited

Equity Metals

Terra Clean Energy

NevGold

MARKETS

COMMODITIES

CURRENCIES